Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mariana Santos Cruz, Joseph Tintelnot & Nicola Gagliani. (2024) Roles of microbiota in pancreatic cancer development and treatment. Gut Microbes 16:1.
Read now
Read now
Jian-Wei Zhang, Dan Zhang, Hai-Sen Yin, Han Zhang, Kun-Qiao Hong, Jing-Ping Yuan & Bao-Ping Yu. (2023) Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretory phenotype via activation of DNA damage response pathway. Gut Microbes 15:1.
Read now
Read now
Hiroo Imai, Ken Saijo, Keigo Komine, Reio Ueta, Ryunosuke Numakura, Shonosuke Wakayama, Sho Umegaki, Sakura Hiraide, Yoshufumi Kawamura, Yuki Kasahara, Kota Ohuchi, Masahiro Takahashi, Shin Takahashi, Hidekazu Shirota, Masanobu Takahashi & Chikashi Ishioka. (2022) Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study. Cancer Management and Research 14, pages 1259-1266.
Read now
Read now
Sarah-Jane Leigh, Caoimhe M.K. Lynch, Brian R. Healey Bird, Brendan T. Griffin, John F. Cryan & Gerard Clarke. (2022) Gut microbiota-drug interactions in cancer pharmacotherapies: implications for efficacy and adverse effects. Expert Opinion on Drug Metabolism & Toxicology 18:1, pages 5-26.
Read now
Read now
Articles from other publishers (15)
Hiroo Imai, Yasuhiro Sakamoto, Shin Takahashi, Hiroyuki Shibata, Atsushi Sato, Kazunori Otsuka, Kenji Amagai, Masanobu Takahashi, Takuhiro Yamaguchi & Chikashi Ishioka. (2024) Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201). BMC Cancer 24:1.
Crossref
Crossref
Inês Mendes & Nuno Vale. (2024) Overcoming Microbiome-Acquired Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma. Biomedicines 12:1, pages 227.
Crossref
Crossref
Vidhi Chandra, Le Li, Olivereen Le Roux, Yu Zhang, Rian M. Howell, Dhwani N. Rupani, Seyda Baydogan, Haiyan D. Miller, Erick Riquelme, Joseph Petrosino, Michael P. Kim, Krishna P.L. Bhat, James R. White, Jay K. Kolls, Yuliya Pylayeva-Gupta & Florencia McAllister. (2024) Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulation. Cancer Cell 42:1, pages 85-100.e6.
Crossref
Crossref
Valerio Papa, Tommaso Schepis, Gaetano Coppola, Michele Francesco Chiappetta, Livio Enrico Del Vecchio, Tommaso Rozera, Giuseppe Quero, Antonio Gasbarrini, Sergio Alfieri & Alfredo Papa. (2023) The Role of Microbiota in Pancreatic Cancer. Cancers 15:12, pages 3143.
Crossref
Crossref
Zetao Han, Haiyan Zhang, Lu Lu, Xin Li, Caoyu Zhang, Jiajie Zhu, Chaonan Li, Qingjing Wang & Keda Chen. (2022) Research Progress in Intestinal Microecology in Pancreatic Cancer Diagnosis and Treatment. Journal of Oncology 2022, pages 1-10.
Crossref
Crossref
Bassel Ghaddar, Antara Biswas, Chris Harris, M. Bishr Omary, Darren R. Carpizo, Martin J. Blaser & Subhajyoti De. (2022) Tumor microbiome links cellular programs and immunity in pancreatic cancer. Cancer Cell 40:10, pages 1240-1253.e5.
Crossref
Crossref
Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau & Jun Yu. (2022) Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes. Gut 71:7, pages 1412-1425.
Crossref
Crossref
Shintaro Nakano, Yasuyuki Kawamoto, Yoshito Komatsu, Rika Saito, Ken Ito, Takahiro Yamamura, Kazuaki Harada, Satoshi Yuki, Kazumichi Kawakubo, Ryo Sugiura, Shin Kato, Koji Hirata, Hajime Hirata, Masahito Nakajima, Ryutaro Furukawa, Yunosuke Takishin, Kousuke Nagai, Isao Yokota, Keisuke H. Ota, Shinji Nakaoka, Masaki Kuwatani & Naoya Sakamoto. (2022) Analysis of the Pancreatic Cancer Microbiome Using Endoscopic Ultrasound–Guided Fine-Needle Aspiration–Derived Samples. Pancreas 51:4, pages 351-357.
Crossref
Crossref
Juqun Xi, Yanqiu Wang, Xuejiao Gao, Yaling Huang, Jie Chen, Yong Chen, Lei Fan & Lizeng Gao. (2022) Reverse intratumor bacteria-induced gemcitabine resistance with carbon nanozymes for enhanced tumor catalytic-chemo therapy. Nano Today 43, pages 101395.
Crossref
Crossref
Hiroaki Shirai, Cocoro Ito & Kosuke Tsukada. (2022) pH-taxis drives aerobic bacteria in duodenum to migrate into the pancreas with tumors. Scientific Reports 12:1.
Crossref
Crossref
Reece J. Knippel, Julia L. Drewes & Cynthia L. Sears. (2021) The Cancer Microbiome: Recent Highlights and Knowledge Gaps. Cancer Discovery 11:10, pages 2378-2395.
Crossref
Crossref
Chirayu Mohindroo, Merve Hasanov, Jane E. Rogers, Wenli Dong, Laura R. Prakash, Seyda Baydogan, Jonathan D. Mizrahi, Michael J. Overman, Gauri R. Varadhachary, Robert A. Wolff, Milind M. Javle, David R. Fogelman, Michael T. Lotze, Michael P. Kim, Matthew H.G. Katz, Shubham Pant, Ching‐Wei D. Tzeng & Florencia McAllister. (2021) Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients. Cancer Medicine 10:15, pages 5041-5050.
Crossref
Crossref
Roberto Mendez, Sulagna Banerjee & Santanu Banerjee. 2021. Inflammation, Infection, and Microbiome in Cancers. Inflammation, Infection, and Microbiome in Cancers
313
327
.
Shintaro Nakano, Yoshito Komatsu, Yasuyuki Kawamoto, Rika SaitoKen ItoHiroshi NakatsumiSatoshi Yuki & Naoya Sakamoto. (2020) Association between the use of antibiotics and efficacy of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer. Medicine 99:39, pages e22250.
Crossref
Crossref
Hiroo Imai, Ken Saijo, Keigo Komine, Yuya Yoshida, Keiju Sasaki, Asako Suzuki, Kota Ouchi, Masahiro Takahashi, Shin Takahashi, Hidekazu Shirota, Masanobu Takahashi & Chikashi Ishioka. (2020) Antibiotics Improve the Treatment Efficacy of Oxaliplatin-Based but Not Irinotecan-Based Therapy in Advanced Colorectal Cancer Patients. Journal of Oncology 2020, pages 1-8.
Crossref
Crossref